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A Multipurpose Prevention Ring
for Women’s Sexual and Reproductive Health
HIV and complications due to unintended pregnancy are among the greatest obstacles to women’s health and
development. Products that simultaneously address both issues could help women stay healthy.
Women’s sexual and reproductive health needs do not exist
in isolation, and meeting those needs is essential to
supporting women’s overall health so they can reach their
full potential.
n Women are disproportionately affected by
HIV/AIDS due to biology, gender inequities and
cultural norms. In sub-Saharan Africa—where the
epidemic’s main driver is heterosexual sex—63% of all
new HIV infections occur among women and girls.i
Young women in the region are three times as likely to
acquire HIV as young men.ii
n In developing countries, a lack of access to contraception is a major contributor to maternal and
newborn deaths, largely due to complications during
pregnancy and childbirth.
Nearly half of all pregnancies in low- and middleincome countries are unintended. An estimated 218
million women of reproductive age—one-quarter
living in sub-Saharan Africa—have an unmet need for
contraceptives that would allow them to space their
pregnancies, and lead to better health, educational and
economic outcomes for women and their families.iii
n Women face dual risks. Women in areas with high
rates of HIV often have the greatest unmet need for
modern contraception.iv Research suggests that women may be two to four times as likely to acquire HIV
during pregnancy and the postpartum period,v and that
women living with HIV/AIDS may face a higher risk of
maternal death than HIV-negative women.vi

Promise of Multipurpose Prevention
New multipurpose products are now being developed to
offer women a single product that offers discreet protection
against the risks associated with HIV and unintended
pregnancy in a single product. Some products may also
prevent other sexually transmitted infections. Although
condoms are highly effective multipurpose prevention
products, it is often difficult for women to negotiate
condom use with their partners.

Because women’s perceived risk of HIV is low compared
to their perceived risk for pregnancy, combined technologies may be attractive to many women. Women in multiple
studies have shown strong interest in and willingness to use
multipurpose rings and other products if proven effective.vii-ix

Three-month Dual
Protection
IPM is leveraging our experience developing the monthly
dapivirine ring to reduce
women’s HIV risk, which has
received a positive European Medicines Agency opinion,
World Health Organization recommendation, and approvals in Zimbabwe and several other countries in eastern and
southern Africa. IPM is developing a three-month vaginal
ring designed to slowly release the ARV drug dapivirine and
the contraceptive hormone levonorgestrel, to help protect
against both HIV and unintended pregnancy.

Integrated Solutions Make Sense
n Discreet, woman-controlled protection against HIV and

unintended pregnancy can help reduce maternal and
newborn deaths
n Long-acting options with dual or multipurpose
protection may help encourage uptake and use

n Integrated sexual & reproductive health care may offer:

 Expanded method mix
 Fewer clinic visits and greater efficiency
 Reduced stigma associated with seeking HIV care
Two safety studies of IPM’s dapivirine-contraceptive ring, led
by the Microbicide Trials Network, found the ring to have a
favorable safety profile and saw encouraging drug levels for
HIV prevention and contraception. IPM has reformulated the
ring to increase its firmness due to some reports of slippage,
and a Phase I trial of the reformulated ring is planned for
2022, in collaboration with the Eunice Kennedy Shriver National Institute of Child Health and Human Development.
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